Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 217

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 217
---
 the Merger Agreement. Prior to the Closing, Enfusion will use its reasonable best efforts to, and will cause its subsidiaries and representatives to use reasonable best efforts to, provide such cooperation as is customary, required and reasonably requested by Clearwater in connection with the obtaining and arranging of the Debt Financing, including using reasonable best efforts to assist in preparing marketing materials, participate in lender meetings, road shows and other similar meetings, provide historical financial statements and financial and other pertinent information required in connection with the Debt Financing and facilitate or provide information for negotiation and execution of the definitive agreements with respect to the Debt Financing. Such cooperation is subject to certain exceptions and limitations specified in the Merger Agreement. Obtaining any financing (including the Debt Financing) is not a condition to the Closing. 137

Employee Matters For a period of one year following the Closing Date, Clearwater has agreed to provide each employee of Enfusion and its subsidiaries who continues employment with Clearwater or any of its subsidiaries following the Effective Time (each, a “ continuing employee”), subject to continued employment with Clearwater or any of its subsidiaries, with:

| • |     | an annual base salary or base hourly wage rate that is no less favorable than the annual base salary or base 
 hourly wage rate for which such continuing employee was eligible immediately prior to the Effective Time;    |

| • |     | target cash incentive compensation opportunities, including commissions, but excluding retention, long-term                                                                                                       
 incentive compensation, change in control, transaction or other one-time or special bonus opportunities and equity or equity-based incentive compensation, in an amount no less favorable than such opportunities 
 that such continuing employee was eligible for immediately prior to the Effective Time; and                                                                                                                       |

| • |     | employee benefits, including severance benefits that would have been provided to such continuing employee under                                                                                                                                           
 the applicable severance benefit plans, programs, policies, agreements and arrangements of Enfusion, defined contribution retirement, health and welfare, vacation and sick or other paid leave and remote working options, but excluding defined benefit 
 pension, equity or equity-based, nonqualified deferred compensation, change in control, retention or retiree health or welfare benefits, that are either, in Clearwater’s discretion, substantially comparable in the aggregate to those provided to      
 such continuing employee immediately prior to the Effective Time or no less favorable in the aggregate than those provided to similarly situated employees of Clearwater or any of its subsidiaries.                                                      |

In addition, from and after the Effective Time, Clearwater will:

| • |     | use reasonable